Home > > > Report Detail

Global Gliclazide Sustained-release Tablet Market Research Report 2023

Publisher Name :
Date: 26-Apr-2023
No. of pages: 97
Inquire Before Buying

The global Gliclazide Sustained-release Tablet market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Gliclazide Sustained-release Tablet include Servier Laboratories, Torrent Pharmaceuticals, Aurobindo Pharma, Teva, Zydus Cadila Healthcare, Sanofi S.A., Mylan Pharmaceuticals, Accord Healthcare and Lukang Jituan Saite Yaoye, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gliclazide Sustained-release Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gliclazide Sustained-release Tablet.

The Gliclazide Sustained-release Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gliclazide Sustained-release Tablet market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gliclazide Sustained-release Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Servier Laboratories

- Torrent Pharmaceuticals

- Aurobindo Pharma

- Teva

- Zydus Cadila Healthcare

- Sanofi S.A.

- Mylan Pharmaceuticals

- Accord Healthcare

- Lukang Jituan Saite Yaoye

- Shijiazhuang SIYAO

- Yiling Pharmaceutical

Segment by Type

- 30mg

- 60mg

- Other

Segment by Application

- Hospital

- Clinic

- Other

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Southeast Asia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Gliclazide Sustained-release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Gliclazide Sustained-release Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Gliclazide Sustained-release Tablet Market Research Report 2023

Table of Contents
1 Gliclazide Sustained-release Tablet Market Overview
1.1 Product Overview and Scope of Gliclazide Sustained-release Tablet
1.2 Gliclazide Sustained-release Tablet Segment by Type
1.2.1 Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2023-2029)
1.2.2 30mg
1.2.3 60mg
1.2.4 Other
1.3 Gliclazide Sustained-release Tablet Segment by Application
1.3.1 Global Gliclazide Sustained-release Tablet Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Gliclazide Sustained-release Tablet Market Size Estimates and Forecasts
1.4.1 Global Gliclazide Sustained-release Tablet Revenue 2018-2029
1.4.2 Global Gliclazide Sustained-release Tablet Sales 2018-2029
1.4.3 Global Gliclazide Sustained-release Tablet Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gliclazide Sustained-release Tablet Market Competition by Manufacturers
2.1 Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gliclazide Sustained-release Tablet Average Price by Manufacturers (2018-2023)
2.4 Global Gliclazide Sustained-release Tablet Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gliclazide Sustained-release Tablet, Product Type & Application
2.7 Gliclazide Sustained-release Tablet Market Competitive Situation and Trends
2.7.1 Gliclazide Sustained-release Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gliclazide Sustained-release Tablet Players Market Share by Revenue
2.7.3 Global Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gliclazide Sustained-release Tablet Retrospective Market Scenario by Region
3.1 Global Gliclazide Sustained-release Tablet Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gliclazide Sustained-release Tablet Global Gliclazide Sustained-release Tablet Sales by Region: 2018-2029
3.2.1 Global Gliclazide Sustained-release Tablet Sales by Region: 2018-2023
3.2.2 Global Gliclazide Sustained-release Tablet Sales by Region: 2024-2029
3.3 Global Gliclazide Sustained-release Tablet Global Gliclazide Sustained-release Tablet Revenue by Region: 2018-2029
3.3.1 Global Gliclazide Sustained-release Tablet Revenue by Region: 2018-2023
3.3.2 Global Gliclazide Sustained-release Tablet Revenue by Region: 2024-2029
3.4 North America Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.4.1 North America Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gliclazide Sustained-release Tablet Sales by Country (2018-2029)
3.4.3 North America Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.5.1 Europe Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gliclazide Sustained-release Tablet Sales by Country (2018-2029)
3.5.3 Europe Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gliclazide Sustained-release Tablet Sales by Country (2018-2029)
3.6.3 Asia Pacific Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.7.1 Latin America Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gliclazide Sustained-release Tablet Sales by Country (2018-2029)
3.7.3 Latin America Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Gliclazide Sustained-release Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Gliclazide Sustained-release Tablet Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gliclazide Sustained-release Tablet Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gliclazide Sustained-release Tablet Sales by Type (2018-2029)
4.1.1 Global Gliclazide Sustained-release Tablet Sales by Type (2018-2023)
4.1.2 Global Gliclazide Sustained-release Tablet Sales by Type (2024-2029)
4.1.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2029)
4.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2018-2029)
4.2.1 Global Gliclazide Sustained-release Tablet Revenue by Type (2018-2023)
4.2.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2024-2029)
4.2.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2018-2029)
4.3 Global Gliclazide Sustained-release Tablet Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gliclazide Sustained-release Tablet Sales by Application (2018-2029)
5.1.1 Global Gliclazide Sustained-release Tablet Sales by Application (2018-2023)
5.1.2 Global Gliclazide Sustained-release Tablet Sales by Application (2024-2029)
5.1.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2029)
5.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2018-2029)
5.2.1 Global Gliclazide Sustained-release Tablet Revenue by Application (2018-2023)
5.2.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2024-2029)
5.2.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2018-2029)
5.3 Global Gliclazide Sustained-release Tablet Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Servier Laboratories
6.1.1 Servier Laboratories Corporation Information
6.1.2 Servier Laboratories Description and Business Overview
6.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio
6.1.5 Servier Laboratories Recent Developments/Updates
6.2 Torrent Pharmaceuticals
6.2.1 Torrent Pharmaceuticals Corporation Information
6.2.2 Torrent Pharmaceuticals Description and Business Overview
6.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
6.2.5 Torrent Pharmaceuticals Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Gliclazide Sustained-release Tablet Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Zydus Cadila Healthcare
6.5.1 Zydus Cadila Healthcare Corporation Information
6.5.2 Zydus Cadila Healthcare Description and Business Overview
6.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio
6.5.5 Zydus Cadila Healthcare Recent Developments/Updates
6.6 Sanofi S.A.
6.6.1 Sanofi S.A. Corporation Information
6.6.2 Sanofi S.A. Description and Business Overview
6.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio
6.6.5 Sanofi S.A. Recent Developments/Updates
6.7 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Corporation Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
6.7.5 Mylan Pharmaceuticals Recent Developments/Updates
6.8 Accord Healthcare
6.8.1 Accord Healthcare Corporation Information
6.8.2 Accord Healthcare Description and Business Overview
6.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio
6.8.5 Accord Healthcare Recent Developments/Updates
6.9 Lukang Jituan Saite Yaoye
6.9.1 Lukang Jituan Saite Yaoye Corporation Information
6.9.2 Lukang Jituan Saite Yaoye Description and Business Overview
6.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio
6.9.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
6.10 Shijiazhuang SIYAO
6.10.1 Shijiazhuang SIYAO Corporation Information
6.10.2 Shijiazhuang SIYAO Description and Business Overview
6.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio
6.10.5 Shijiazhuang SIYAO Recent Developments/Updates
6.11 Yiling Pharmaceutical
6.11.1 Yiling Pharmaceutical Corporation Information
6.11.2 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Description and Business Overview
6.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio
6.11.5 Yiling Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gliclazide Sustained-release Tablet Industry Chain Analysis
7.2 Gliclazide Sustained-release Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gliclazide Sustained-release Tablet Production Mode & Process
7.4 Gliclazide Sustained-release Tablet Sales and Marketing
7.4.1 Gliclazide Sustained-release Tablet Sales Channels
7.4.2 Gliclazide Sustained-release Tablet Distributors
7.5 Gliclazide Sustained-release Tablet Customers
8 Gliclazide Sustained-release Tablet Market Dynamics
8.1 Gliclazide Sustained-release Tablet Industry Trends
8.2 Gliclazide Sustained-release Tablet Market Drivers
8.3 Gliclazide Sustained-release Tablet Market Challenges
8.4 Gliclazide Sustained-release Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gliclazide Sustained-release Tablet Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gliclazide Sustained-release Tablet Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gliclazide Sustained-release Tablet Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gliclazide Sustained-release Tablet Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gliclazide Sustained-release Tablet, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Product Type & Application
Table 12. Global Key Manufacturers of Gliclazide Sustained-release Tablet, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gliclazide Sustained-release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gliclazide Sustained-release Tablet as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gliclazide Sustained-release Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gliclazide Sustained-release Tablet Sales by Region (2018-2023) & (K Units)
Table 18. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2018-2023)
Table 19. Global Gliclazide Sustained-release Tablet Sales by Region (2024-2029) & (K Units)
Table 20. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2024-2029)
Table 21. Global Gliclazide Sustained-release Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2018-2023)
Table 23. Global Gliclazide Sustained-release Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2024-2029)
Table 25. North America Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 27. North America Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)
Table 28. North America Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gliclazide Sustained-release Tablet Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gliclazide Sustained-release Tablet Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gliclazide Sustained-release Tablet Sales (K Units) by Type (2018-2023)
Table 51. Global Gliclazide Sustained-release Tablet Sales (K Units) by Type (2024-2029)
Table 52. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
Table 53. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2024-2029)
Table 54. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2018-2023)
Table 57. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2024-2029)
Table 58. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2018-2023)
Table 59. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2024-2029)
Table 60. Global Gliclazide Sustained-release Tablet Sales (K Units) by Application (2018-2023)
Table 61. Global Gliclazide Sustained-release Tablet Sales (K Units) by Application (2024-2029)
Table 62. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)
Table 63. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2024-2029)
Table 64. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gliclazide Sustained-release Tablet Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2018-2023)
Table 67. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2024-2029)
Table 68. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2018-2023)
Table 69. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2024-2029)
Table 70. Servier Laboratories Corporation Information
Table 71. Servier Laboratories Description and Business Overview
Table 72. Servier Laboratories Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Servier Laboratories Gliclazide Sustained-release Tablet Product
Table 74. Servier Laboratories Recent Developments/Updates
Table 75. Torrent Pharmaceuticals Corporation Information
Table 76. Torrent Pharmaceuticals Description and Business Overview
Table 77. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product
Table 79. Torrent Pharmaceuticals Recent Developments/Updates
Table 80. Aurobindo Pharma Corporation Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Aurobindo Pharma Gliclazide Sustained-release Tablet Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Teva Gliclazide Sustained-release Tablet Product
Table 89. Teva Recent Developments/Updates
Table 90. Zydus Cadila Healthcare Corporation Information
Table 91. Zydus Cadila Healthcare Description and Business Overview
Table 92. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product
Table 94. Zydus Cadila Healthcare Recent Developments/Updates
Table 95. Sanofi S.A. Corporation Information
Table 96. Sanofi S.A. Description and Business Overview
Table 97. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sanofi S.A. Gliclazide Sustained-release Tablet Product
Table 99. Sanofi S.A. Recent Developments/Updates
Table 100. Mylan Pharmaceuticals Corporation Information
Table 101. Mylan Pharmaceuticals Description and Business Overview
Table 102. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product
Table 104. Mylan Pharmaceuticals Recent Developments/Updates
Table 105. Accord Healthcare Corporation Information
Table 106. Accord Healthcare Description and Business Overview
Table 107. Accord Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Accord Healthcare Gliclazide Sustained-release Tablet Product
Table 109. Accord Healthcare Recent Developments/Updates
Table 110. Lukang Jituan Saite Yaoye Corporation Information
Table 111. Lukang Jituan Saite Yaoye Description and Business Overview
Table 112. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product
Table 114. Lukang Jituan Saite Yaoye Recent Developments/Updates
Table 115. Shijiazhuang SIYAO Corporation Information
Table 116. Shijiazhuang SIYAO Description and Business Overview
Table 117. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product
Table 119. Shijiazhuang SIYAO Recent Developments/Updates
Table 120. Yiling Pharmaceutical Corporation Information
Table 121. Yiling Pharmaceutical Description and Business Overview
Table 122. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product
Table 124. Yiling Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Gliclazide Sustained-release Tablet Distributors List
Table 128. Gliclazide Sustained-release Tablet Customers List
Table 129. Gliclazide Sustained-release Tablet Market Trends
Table 130. Gliclazide Sustained-release Tablet Market Drivers
Table 131. Gliclazide Sustained-release Tablet Market Challenges
Table 132. Gliclazide Sustained-release Tablet Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gliclazide Sustained-release Tablet
Figure 2. Global Gliclazide Sustained-release Tablet Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gliclazide Sustained-release Tablet Market Share by Type in 2022 & 2029
Figure 4. 30mg Product Picture
Figure 5. 60mg Product Picture
Figure 6. Other Product Picture
Figure 7. Global Gliclazide Sustained-release Tablet Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Gliclazide Sustained-release Tablet Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Gliclazide Sustained-release Tablet Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gliclazide Sustained-release Tablet Market Size (2018-2029) & (US$ Million)
Figure 14. Global Gliclazide Sustained-release Tablet Sales (2018-2029) & (K Units)
Figure 15. Global Gliclazide Sustained-release Tablet Average Price (US$/Unit) & (2018-2029)
Figure 16. Gliclazide Sustained-release Tablet Report Years Considered
Figure 17. Gliclazide Sustained-release Tablet Sales Share by Manufacturers in 2022
Figure 18. Global Gliclazide Sustained-release Tablet Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Gliclazide Sustained-release Tablet Players: Market Share by Revenue in 2022
Figure 20. Gliclazide Sustained-release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Gliclazide Sustained-release Tablet Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)
Figure 23. North America Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)
Figure 24. United States Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)
Figure 27. Europe Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)
Figure 28. Germany Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Gliclazide Sustained-release Tablet Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Gliclazide Sustained-release Tablet Revenue Market Share by Region (2018-2029)
Figure 35. China Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)
Figure 43. Latin America Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Gliclazide Sustained-release Tablet Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Gliclazide Sustained-release Tablet by Type (2018-2029)
Figure 54. Global Revenue Market Share of Gliclazide Sustained-release Tablet by Type (2018-2029)
Figure 55. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Gliclazide Sustained-release Tablet by Application (2018-2029)
Figure 57. Global Revenue Market Share of Gliclazide Sustained-release Tablet by Application (2018-2029)
Figure 58. Global Gliclazide Sustained-release Tablet Price (US$/Unit) by Application (2018-2029)
Figure 59. Gliclazide Sustained-release Tablet Value Chain
Figure 60. Gliclazide Sustained-release Tablet Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs